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Background: Enterovirus 71 (EV71) is the main causative agent of hand, foot and mouth disease that occurs in
young children. Neither antiviral agents nor vaccines are available for efficiently combating viral infection. Study of
EV71–host interplay is important for understanding viral infection and developing strategies for prevention and
therapy. Here the interactions of EV71 with human dendritic cells were analyzed.
Methods: EV71 capture, endocytosis, infection, and degradation in monocyte-derived dendritic cells (MDDCs) were
detected by Flow cytometry or real-time (RT-) PCR, and MDDCs-mediated EV71 trans-infection of RD cells was
determined via coculture system. Cell morphology or viability was monitored with microscopy or flow cytometry.
SiRNA interference was used to knock down gene expression.
Results: MDDCs can bind EV71, but these loaded-EV71 particles in MDDCs underwent a rapid degradation in the
absence of efficient replication; once the captured EV71 encountered susceptible cells, MDDCs efficiently transferred
surface-bound viruses to target cells. The molecule of DC-SIGN (DC-specific intercellular adhesion molecule-3
grabbing nonintegrin) mediated viral binding and transfer, because interference of DC-SIGN expression with
specific siRNAs reduced EV71 binding and impaired MDDC-mediated viral trans-infection, and exogenous expression of
DC-SIGN molecule on Raji cell initiated viral binding and subsequent transmission.
Conclusion: MDDCs could bind efficiently EV71 viruses through viral binding to DC-SIGN molecule, and these
captured-viruses could be transferred to susceptible cells for robust infection. The novel finding of DC-mediated EV71
dissemination might facilitate elucidation of EV71 primary infection and benefit searching for new clues for preventing
viruses from initial infection.
Keywords: Enterovirus 71, Dendritic cells, Viral trans-infectionBackground
Enterovirus 71 (EV71) and coxsackievirus A16 (CVA16)
belong to the Picornaviridae family, and they are the
main causative agents of hand, foot and mouth disease
in young children [1-5]. There is no antiviral agent
available and vaccine development is still ongoing
[6-12]. EV71 invades mainly via the oropharyngeal or
intestinal mucosa [13-15]. The initial viral expansion
mainly occurs in lymphoid tissues and regional lymph* Correspondence: hbwang@sibs.ac.cn
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unless otherwise stated.nodes. The produced viruses circulate in the blood, and
after replication in reticuloendothelial tissues, liver and
spleen, they give rise to viremia and onset of clinical
features [13-15]. However, which host cells in the
mucosa are primarily targeted by EV71, for mediating
viral capture, spread and initial infection, remains
poorly understood.
Several host molecules have been recently reported to
mediate EV71 binding and infection. P-selectin glyco-
protein ligand (PSGL)-1 and scavenger receptor class B,
membrane 2 (SCARB2) serve as EV71 functional recep-
tors [16-22]. SCARB2 is mainly expressed in intracellular
endosomes and lysosomes and can also be used by. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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dantly expressed by respiratory and gastrointestinal epi-
thelia cells, are reported to be used by EV71 for infection
of intestinal cells [4]. Human annexin II protein can bind
to capsid protein VP1 for enhancing EV71 infectivity [23].
Additionally, dendritic cell (DC)-specific intercellular
adhesion molecule-3 grabbing nonintegrin (DC-SIGN)
is another molecule that has been found to mediate
partially EV71 entry into DCs [24]. Enteroviruses may
retain strain-specific usage of diverse receptors for in-
fection [25].
DCs are pivotal immune cells in modulating host im-
munity, however, they can be hijacked by several viruses
for spread [26-28]. The interactions between DCs and
viruses play a key role in viral pathogenesis. However,
few studies have investigated the interaction between
EV71 and DCs. Here, we show that DCs capture EV71
through viral binding to DC-SIGN, and these surface-
bound infectious particles can be transferred to encoun-
tered susceptible cells for replication amplification. The
understanding of DC and EV71 interplay could facilitate
the elucidation of EV71 primary infection and benefit the


















Figure 1 EV71 viruses bind to MDDCs. (A) Expression of EV71 receptors
and measured with flow cytometry for expression of PSGL-1 and DC-SIGN.
MDDCs. MDDCs were incubated with EV71 or CVA16 viruses for 1 h at 4°C (M
viruses were measured with flow cytometry through immunostaining with an
similar results is shown.Results
MDDCs can efficiently bind EV71
Expression of some identified EV71 receptors or attach-
ment factors, PSGL-1 and DC-SIGN was monitored in
MDDCs by flow cytometry. PSGL-1 and DC-SIGN were
observed for abundant expression on the MDDC surface
(Figure 1).
To investigate infection of MDDCs with EV71, viral
binding was first assessed. At 4°C, 69% of MDDCs were
positive for EV71 binding, as tested with immunostaining
of VP1 and quantified by flow cytometry, and the majority
of bound viruses were removed from the cell surface with
trypsin treatment, and the lower amount of viruses input
generated lower viral binding, indicating the dose-
dependent effect (Figure 1B). These data demonstrate that
MDDCs can efficiently bind EV71 onto cell surface.
CVA16 is another causative agent of HFMD but not
causing CNS diseases. We found that MDDCs could also
efficiently bind CVA16 (64.7%, in Figure 1C) as much as
EV71 (69%, in Figure 1B). Both EV71 and CVA16 can bind
MDDCs efficiently, which may suggest that the initially
viral attachment is not the key cause for these two kinds














or attachment factors in MDDCs. MDDCs cells were immunostained
The positive expression percentage is noted. (B,C) Viral binding to
OI 0.3 or 0.1). Some samples were treated with trypsin. Surface-bound
ti-VP1 polyclonal antibodies. One representative donor from four with
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degradation
We demonstrated above the efficient binding of EV71 to
MDDCs. To examine further the potential infection of
MDDCs by EV71 in our culture system, varied amounts
of infectious EV71 were inoculated to MDDCs at 37°C,
and these surface-bound viruses were removed by tryp-
sin treatment. Viral replication was evaluated at the indi-
cated time post-infection by quantifying relatively viral
mRNA. No accumulation of EV71 mRNA was observed
at 1, 3 and 5 days post-infection (Figure 2A). Instead,
EV71 was rapidly degraded in MDDCs, which was
assessed through intensive analysis of time-course cul-
ture (Figure 2B). As a control, these input EV71 viruses
could efficiently and productively infect susceptible RD
cells, as viral mRNA was detected 1 day post-infection
(Figure 2C). Together, these data indicate that MDDCs
do not support efficient replication of EV71; instead,
and loaded viruses exhibit a short period of intracellu-
lar retention.
MDDCs can mediate EV71 trans-infection
DCs can be hijacked by multiple viruses for capture and
transfer to susceptible cells for robust infection [26-28]; a
process defined as trans-infection. To investigate whether
MDDCs can mediate trans-infection of surface-bound
EV71, coculture of virus-pulsed MDDCs with susceptible
RD cells was used. As shown in Figure 3A, EV71 could be





































































Figure 2 EV71 uptake and replication. MDDCs or RD cells were incubate
surface-bound viruses. Viral uptake and replication were quantified by dete
0.1, and (B) MOI 1. One representative from three donors with similar resul
were considered significant differences in paired t test.infection. Efficient EV71 transfer between cells depended
on MDDC and RD cell contact, because viral transfer
was significantly inhibited when virus-captured MDDCs
were separated from RD cells with Transwell plates (insert
membrane size, 0.4 μm) (Figure 3B).
Infection with EV71 can induce apoptosis of multiple
types of host cells [29-36]. We demonstrated that robust
infection of transferred EV71 also induced killing of
RD cells (CD11c-negative), as measured by PI exclusion
staining, but MDDC viability (CD11c-positive) was not
greatly affected (Figure 3C). Cell death could also be
observed from the altered cell morphology (Figure 3D).
Taken together, these data demonstrate that MDDCs
can mediate trans-infection of surface-bound EV71 upon
contact with susceptible RD cells, and robust infection of
transferred viruses can induce death of RD target cells.
DC-SIGN molecule mediates viral binding and
trans-infection
The molecule of DC-SIGN has been widely described to
capture multiple kinds of viruses for subsequent dissem-
ination to susceptible cells [27,28]. To determine the
role of DC-SIGN molecule in EV71 binding, expression
of DC-SIGN was knocked down with specific siRNA
(Figure 4A), and the surface-bound EV71 was quantified.
Knockdown of DC-SIGN significantly impaired EV71
binding to MDDCs by detecting viral mRNA (Figure 4B).
The bound-viruses also were quantified with immuno-























d with EV71 for 1 h at 37°C, and then treated with trypsin to remove
cting viral RNA level at the indicated time post-infection. (A, C) MOI
ts is shown. Data are mean ± SD. ***P <0.001, **P <0.01, and *P <0.05






















































































Figure 3 MDDCs transfer EV71 to susceptible cells. (A) MDDC-mediated EV71 transmission. MDDCs were incubated with different amounts of
EV71 for 1 h at 37°C, after washing, EV71-loaded MDDCs were cocultured or not (DC alone) with RD cells for 1 day. Viral replication was detected
by quantifying viral mRNA level. One representative from three donors or repeats with similar results is shown. (B) Separation of MDDCs with RD
cells abolished EV71 transfer. EV71-loaded MDDCs were separated from RD cells by Transwell insert, and viral transmission was detected as above.
(C, D) Replication of transferred-EV71 killed RD target cells. PI-exclusion staining was used to examine cell death during coculture, and MDDCs
(CD11c+) and RD cells (CD11c−) were distinguished by CD11c staining (C), and cell death was observed under light microscopy (D). Data are
mean ± SD. ***P <0.001 and *P <0.05 were considered significant differences in paired t test.
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of DC-SIGN decreased the percentage of positive cells, in-
dicating the less viral binding (Figure 4C). Consequently,
the knockdown of DC-SIGN also reduced significantly
MDDC-mediated EV71 trans-infection (Figure 4D).
The role of DC-SIGN in binding and trans-infection
of EV71 was further evaluated on DC-SIGN-expressing
Raji cell derivatives (Figure 4E). No expression of PSGL-1
was observed on either cell type (Figure 4E). Exogenousexpression of DC-SIGN on Raji cells facilitated cell surface
binding of EV71 virus, when performed at 4°C (Figure 4F).
No replication of EV71 in either Raji or Raji/DC-SIGN
cells was observed (data not shown). Moreover, these
bound-EV71 viruses on Raji/DC-SIGN cells could also be
transferred to RD cells (Figure 4G), demonstrating the role
of DC-SIGN in mediating EV71 trans-infection. Overall,
these data demonstrate that DC surface-expressed DC-





















































































































































Figure 4 (See legend on next page.)
Ren et al. Virology Journal 2014, 11:47 Page 5 of 9
http://www.virologyj.com/content/11/1/47
(See figure on previous page.)
Figure 4 DC-SIGN molecule mediates viral surface binding and transfer. (A) Knocking-down of DC-SIGN expression in MDDCs. Expression of
DC-SIGN was interfered with by specific siRNAs, and detected by flow cytometry, the positive expression percentage is shown; (B, C) Interference
of DC-SIGN expression impaired EV71 binding as quantified by detecting viral mRNA (B) and by measuring with flow cytometry (C). (D) DC-SIGN
Knocking-down impaired MDDC-mediated EV71 trans-infection of RD cells. Data are mean ± SD. ***P <0.001, **P <0.01, were considered significant
differences in paired t test. (E, F, G) Raji/DC-SIGN cells mediate EV71 binding and transmission. Parental Raji cells and DC-SIGN-expressing derivative
were tested for expression of DC-SIGN and PSGL-1 with flow cytometry (E). EV71 was added to cells (MOI 0.3) for viral binding at 4°C, and bound vi-
ruses were quantified by flow cytometry (F), and in (G) Raji and Raji/DC-SIGN cells were incubated with different amounts of EV71 for 1 h at 37°C, after
washing, cells were cocultured with RD cells for 1 day, and viral replication was detected as above. One representative from three repeats is shown.
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The study of EV71–host interplay is of importance for
understanding viral infection and could benefit design
strategies for prevention and therapy [37,38]. Here, we
show that DCs can transfer surface-bound EV71 to sus-
ceptible RD cells for robust infection, although no ap-
parent viral replication in MDDCs was observed. The
surface-expressing viral attachment factor DC-SIGN me-
diates EV71 binding and transfer.
DC-SIGN has been shown to be hijacked by several
types of viruses for mediating capture and transmission
[27,28]. DC-SIGN can bind high-mannose-containing
glycoproteins, such as HIV-1 gp120 and HCV E1 and E2
glycoprotein [27]. DC-SIGN has been demonstrated to
mediate partially EV71 binding to MDDCs [24], although
the specific molecular basis of EV71 that accounts for
binding to DC-SIGN needs to be further clarified.
DC-SIGN also can mediate viral endocytosis [39], and
here, we observed EV71 internalization into MDDCs.
Whether DC-SIGN plays a role in viral endocytosis needs
to be further examined. A recent publication reported that
both SCARB2 and PSGL-1 could bind EV71 viruses when
these receptors were stably expressed on mouse L929
cells, and SCARB2 efficiently mediated viral internaliza-
tion and uncoating [18]. Clathrin-mediated endocytosis
has been reported to act as an entry pathway for EV71
infection of susceptible RD cells [40]. However, despite
EV71 binding and endocytosis into MDDCs, no appar-
ent viral infection was observed, and these internalized
viruses were rapidly degraded. The contradiction be-
tween EV71 infection of MDDCs in the present and
other studies may be due to different viral strains and
infection situations [24].
EV71 replication causes apoptosis of a wide range of
host cells, such as human glioblastoma cells, micro-
vascular endothelial cell line, neural cells, RD cells, Vero
cells, HeLa cells, and Jurkat T cells [29-33,35,36]. Simi-
larly, the replication of transferred EV71 mediated by
MDDCs also induced RD cell death in our study, while
MDDC viability was not greatly affected. The cell select-
ivity might have been due to the lower susceptibility of
MDDCs for EV71 replication. The pathways of EV71-
induced apoptosis remain elusive [34,36,41]. EV71 infec-
tion can induce Fas ligand expression on Jurkat T cells[42] and trigger activation of caspase 3 and 8 and poly
(ADP-ribose) polymerases in RD cells [36]. Viral protein
synthesis appears to be required for inducing cell apop-
tosis, and expression of 2A and 3C proteases is associ-
ated with induction of apoptosis [31,32]. Blocking with
specific antibodies such as DC-SIGN prior to EV71 in-
fection could provide an alternative approach for blocking
viral replication and viremia by reducing viral binding and
transmission mediated by MDDCs.
Overall, although the in vivo investigation needs to be fur-
ther clarified, our in vitro findings hint at the potential role
of DCs in EV71 primary infection and may benefit the
search for new ways to prevent viruses from initial infection.
Conclusion
In this study, we demonstrated that MDDCs could bind
efficiently EV71 viruses through viral binding to DC-SIGN
molecule, and these captured-viruses could be transferred
to susceptible cells for robust infection. The novel finding
of DC-mediated EV71 dissemination might facilitate eluci-
dation of EV71 primary infection and benefit searching for
new clues for preventing viruses from initial infection.
Methods
Cells
Human peripheral blood mononuclear cells (PBMCs) were
purchased from the Blood Center of Shanghai, China.
CD14+ monocytes were purified from PBMCs using
anti-CD14 specific antibody-coated microbeads (Miltenyi
Biotec). Monocyte-derived DCs (MDDCs) were generated
by stimulation of monocytes with 50 ng/ml granulo-
cyte–macrophage colony-stimulating factor (GM-CSF)
(R&D Systems) and interleukin (IL)-4 (R&D Systems)
for 5 days, and MDDCs show the phenotype of DC-
SIGN+CD11c++HLA-DR+CD14-/lowCD3−CD19−. RD cells
(rhabdomyosarcoma) (ATCC# CCL-136) were maintained
in Dulbecco’s Modified Eagle’s Medium (DMEM; Hyclone)
containing 10% fetal bovine serum (FBS; Hyclone) with 100
U/ml penicillin and 100 μg/ml streptomycin. Raji and Raji/
DC-SIGN (kind gifts from Dr. Vineet Kewal Ramani,
National Cancer Institute, USA) have been described
previously [43], and cells were maintained in RPMI
1640 medium containing 10% FBS with 100 U/ml peni-
cillin and 100 μg/ml streptomycin.
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EV71 (G08-2 strain) and CVA16 (SHZH05-1 strain,
GenBank# EU262658) were propagated in RD cells as
previously described [44,45]. RD cells with 80% conflu-
ence were inoculated with EV71 at 37°C for 1 h with oc-
casional shaking, and were incubated after washing in
DMEM supplemented with 2% FBS until a 90% cyto-
pathic effect was reached. Cell pellets were harvested
and subjected to three freeze–thaw cycles to release the
intracellular virus particles. Viral aliquots were stored at
–80°C, and virus titers were determined by microtitra-
tion using RD cells, which were expressed as the 50%
tissue culture infectious dose (TCID50), according to the
Reed–Muench method.
Flow cytometry
Expression of PSGL-1, DC-SIGN and SCARB2 was
assessed with flow cytometry. The following antibodies
or isotype-matched IgG were used (clone numbers and
resources are given in parentheses): PE-anti-DC-SIGN
(eB-h209; eBioscience) and purified anti-PSGL-1 mono-
clonal antibody (KPL-1; BD Pharmingen), followed by
staining with secondary anti-mouse antibodies. Stained
cells were detected with an LSRII flow cytometer (BD
Biosciences Pharmingen) and analyzed with FlowJo 7.6.1
software (TreeStar Inc.).
Viral binding, endocytosis and infection
For the binding assay, MDDCs or Raji or Raji/DC-SIGN
cells (2×105/sample) were incubated with EV71 (4×105
TCID50) for 1 h at 4°C. Some samples were digested
with 0.25% trypsin for 5 min. The bound viruses were
then stained with VP1 polyclonal antibody, followed by
Alexa Fluor 568-goat anti-rabbit IgG (Invitrogen). The
anti-VP1 polyclonal antibody was generated by
immunization of rabbits with recombinant EV71 VP1
protein produced from Escherichia coli, and this anti-
body was found to cross-react strongly with CVA16
[44]. For viral endocytosis or infection assay, MDDCs or
RD cells were inoculated with different amounts of
EV71 for 1 h at 37°C; cells were then treated with 0.25%
trypsin for 5 min to remove surface-bound viruses, and
cultured and harvested at the indicated time. Viral reten-
tion or infection was assessed by relative quantification
of EV71 mRNA levels.
Real-time PCR
Total RNAs from differently treated MDDCs or RD cells
were extracted by using TRIzol Reagent (Invitrogen), and
were reverse transcribed into cDNA by performing the
ReverseAid™ First strand cDNA synthesis Kit (Fermentas)
according to the manufacturer’s instructions. Two microli-
ters of cDNA reaction was amplified using forward and re-
verse primers for either EV71 genome or β-actin. Primerswere listed as below: EV71-F, 5′-CCCTGAATGCGGCT
AATCC-3′, and EV71-R, 5′-ATTGTCACCATAAGCA
GCCA-3′; β-Actin-F, 5′-GGGAAATCGTGCGTGACA
T-3′, and β-Actin-R, 5′-GTCAGGCAGCTCGTAGCTC
TT-3′. Real-time PCR was carried out by using the Thun-
derbird SYBR qPCR Mix (TOYOBO) with the thermal
cycling conditions: initial denaturation at 95°C for 10 min,
40 cycles of denaturation at 95°C for 15 s, primer anneal-
ing at 60°C for 15 s, and extension at 72°C for 30 s,
followed by final extension at 72°C for 6 min. The level
of EV71 RNA was expressed as fold change relative to
β-actin.
EV71 transmission
MDDCs, Raji or Raji/DC-SIGN cells (3 × 105 each) were
inoculated with different amount of infectious EV71 for
1 h at 37°C. Cells were washed to remove cell-free vi-
ruses and cocultured with RD cells (8 × 105) for an add-
itional 24 h. In some samples, a Transwell plate with an
insert membrane size of 0.4 μm was used to separate
MDDCs from RD cells. Viral transmission was quanti-
fied by detecting EV71 mRNA level relative to β-actin.
Cell morphology was observed under a light microscope
(Leica), and cell killing was measured by using propi-
dium iodide (PI) (Invitrogen) exclusion staining, and
MDDCs and RD cells were distinguished with immuno-
staining with APC-Alexa Fluor750-CD11c (B-ly6; BD
Biosciences Pharmingen).
siRNA interference
MDDCs were transfected with specific duplex siRNA of
DC-SIGN or off-target control (GenePharma). Amaxa
human dendritic cell nucleofector kit (Amaxa) was used
for transfection according to the manufacturer’s in-
structions. Cells were harvested to confirm the knock-
down of target genes with flow cytometry. Viral binding
and transmission were investigated as described above.
The sequences of siRNA duplex were listed as below:
DC-SIGN siRNA-1:5′-GGAAUGGACAUUCUUCCAA
TT-3′(sense), 5′-UUGGAAGAAUGUCCAUUCCTT-3′




Statistical analysis was performed using a paired t test
with SigmaStat 2.0 (Systat Software, San Jose, CA, USA).
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